During these uncertain times, it’s essential that we stay informed and pragmatic about solutions to #COVID19. Remdesivir, an antiviral drug that had previously been tried with the SARS and Ebola outbreaks, has seen early success in trial data suggesting that the drug could be potentially used to reduce the length of a sickness with the virus. Learn more about how the drug might help #COVID19 patients recover and alleviate hospital capacity from our public health lead, Dr. Kelly Henning. | Bloomb